Physician profile
Sanjay A Samy
NPI 1194763409
$19,809.49
in general payments reported to CMS, 2019-2025
32 companies · $4,477 in 2025
The $4,477 reported for 2025 was more than what 81% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,931 · 2020: $2,778 · 2021: $598 · 2022: $975 · 2023: $2,539 · 2024: $3,512 · 2025: $4,477.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,500 · Food and Beverage: $3,779 · Travel and Lodging: $249.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,500.00 |
| Food and Beverage | $3,778.68 |
| Travel and Lodging | $248.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $9,084.83 | 2019-2025 | Inspiris Resilia Aortic Valve, Mitris Resilia Mitral Valve |
| Abbott Laboratories | $5,507.97 | 2019-2024 | Epic, Thoratec Heartmate 3 Lvas Implant Kit |
| Abiomed | $1,665.90 | 2019-2025 | Impella |
| Livanova USA, INC. | $611.20 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $541.50 | 2020-2023 | Sternalock Blu System |
| Atricure, INC. | $423.90 | 2023-2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Depuy Synthes Sales INC. | $309.65 | 2020-2025 | Matrixrib |
| Baxter Healthcare | $278.75 | 2019-2025 | Tisseel, Preveleak, Coseal |
| Medistim USA, INC. | $198.37 | 2020-2023 | Miraq |
| Bolton Medical INC | $135.40 | 2021-2024 | Treo Abdominal Stent-Graft System |
| Artivion, INC. | $130.67 | 2021-2024 | On-X Aortic Heart Valve With Conform-X Sewing Ring and Extended Holder, Amds-Ascyrus Medical, Bioglue Surgical Adhesive |
| Lemaitre Vascular, INC. | $118.77 | 2023-2024 | Tyke, Patch, Pledget and Intracardiac, Cardiocel, Hydro Lemaitre Valvulotome |
| La Jolla Pharmaceutical Company | $116.07 | 2019 | |
| Boston Scientific Corporation | $78.85 | 2019-2022 | |
| Pfizer INC. | $61.27 | 2022-2023 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $55.75 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $54.86 | 2019-2020 | |
| Medtronic Vascular, INC. | $52.59 | 2019 | |
| Elutia, INC. | $41.85 | 2020 | |
| Integra Lifesciences Corporation | $41.48 | 2023 | Codman Certas, Cusa Clarity, Codman Hakim |
| Teleflex LLC | $36.16 | 2022 | |
| Amgen INC. | $36.01 | 2020-2021 | |
| Lsi Solutions INC | $35.47 | 2024 | Cor-Knot |
| Janssen Pharmaceuticals, INC | $32.94 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $28.61 | 2022 | |
| Dilon Technologies, INC. | $27.91 | 2025 | Hemoblast Bellows |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $25.09 | 2024-2025 | |
| Haemonetics Corporation | $24.43 | 2025 | Teg6s Hemostasis System |
| Smith+Nephew, INC. | $20.26 | 2024 | Pico 7 |
| Sanofi-Aventis U.S. LLC | $19.32 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.66 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sanjay Samy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.